SMSPHARMA.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 05, 2026

Report Source: 2026 3rd Quarter Report

SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Ltd. Stock Analysis SMSPHARMA.NS

India Health Care Small Cap Report:
SMS Pharmaceuticals Ltd. is a holding company, which engages in the research, development and marketing of active pharmaceutical ingredients. The company is headquartered in Hyderabad, Telangana and currently employs 1,470 full-time employees. The company went IPO on 2007-02-25. The firm is engaged in the business of manufacturing active pharma ingredients and their intermediates. Its product categories include anti-ulcer, anti-inflammatory, anti-migraine, ant-diabetic, anti-coagulant, anti-viral, anti-retroviral, anti-psychotic, and others. The firm products include ranitidine, famotidine, pantoprazole sodium, itraconazole, lanoconazole, luliconazole, ibuprofen, Dex ibuprofen, fenoprofen calcium, sumatriptan, almotriptan, zolmitriptan, rizatriptan, Ele triptan, vildagliptin, sitagliptin, rosiglitazone, empagliflozin, dapagliflozin, tenofovir, dolutegravir, raltegravir, lamivudine, efavirenz, apixaban, rivaroxaban, levetiracetam, perampanel, lamotrigine, penciclovir, valaciclovir, and others. The firm has manufacturing facilities at Bachupally, Hyderabad, Telangana and also at Kandivalasa Village, Poosapatirega Mandal, Vijayanagaram District, Andhra Pradesh.
Read More

SMS Pharmaceuticals Ltd (SMSPHARMA.NS) Chart

Key Statistics of SMS Pharmaceuticals Ltd (SMSPHARMA.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹396.65₹407.40

Today's Open

₹399.50

Volume

111.63K

P/E Ratio (TTM)

54.61

52 Week Range

₹207.70₹447.80

Market Cap

37.96B

Avg. Volume

280.46K

Dividend Yield

0.18%

Financial Metrics & Statements of SMS Pharmaceuticals Ltd (SMSPHARMA.NS)

FAQ's for SMS Pharmaceuticals Ltd (SMSPHARMA.NS)

  • According to Musaffa’s Shariah screening methodology, SMS Pharmaceuticals Ltd (SMSPHARMA.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.